MilliporeSigma
  • Home
  • Search Results
  • Toward the development of chemoprevention agents. Part 1: Design, synthesis, and anti-inflammatory activities of a new class of 2,5-disubstituted-dioxacycloalkanes.

Toward the development of chemoprevention agents. Part 1: Design, synthesis, and anti-inflammatory activities of a new class of 2,5-disubstituted-dioxacycloalkanes.

Bioorganic & medicinal chemistry (2007-05-22)
Keli Gu, Lanrong Bi, Ming Zhao, Chao Wang, Jingfang Ju, Shiqi Peng
ABSTRACT

A new class of 2,5-disubstituted-dioxacycloalkanes were designed and synthesized via stereoselective synthetic method as cancer chemoprevention agents. The anti-inflammatory activities of these compounds were tested using the xylene-induced mouse ear edema model. Some of these compounds exhibited comparable or better anti-inflammatory activities than that of aspirin suggesting that they can be further developed as potential anti-inflammatory drug lead compounds. In addition, treatment of these anti-inflammatory agents did not prolong tail bleeding time in mice. The structure/activity relationships were also analyzed among these compounds.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Acetylsalicylic acid, ≥99.0%
Sigma-Aldrich
Cinnamaldehyde, natural, ≥95%, FG
Sigma-Aldrich
p-Tolualdehyde, 97%
Sigma-Aldrich
Benzaldehyde, puriss. p.a., ≥99.0% (GC)
Sigma-Aldrich
p-Tolualdehyde, ≥97%, FG
Sigma-Aldrich
Benzaldehyde, ≥98%, FG, FCC
Sigma-Aldrich
Acetylsalicylic acid, analytical standard
Sigma-Aldrich
4-Chlorobenzaldehyde, 97%
Supelco
Benzaldehyde, analytical standard
Sigma-Aldrich
Benzaldehyde, natural, FCC, FG
Sigma-Aldrich
Benzaldehyde, purified by redistillation, ≥99.5%
Sigma-Aldrich
Benzaldehyde, ReagentPlus®, ≥99%
Sigma-Aldrich
Aspirin, meets USP testing specifications
Sigma-Aldrich
trans-Cinnamaldehyde, 99%
Sigma-Aldrich
trans-Cinnamaldehyde, ≥99%
Sigma-Aldrich
trans-Cinnamaldehyde, FCC, FG